曹娟 李平

    *基金项目：宜春市科技计划项目(2023ZDJH2772)

    【摘要】 目的：探究纤溶酶注射液联合注射用曲克芦丁治疗急性脑梗死(ACI)的效果。方法：选取宜春市第二人民医院2022年1月—2023年8月收治的70例ACI患者为研究对象，采用随机数字表法将其分为对照组和观察组，每组35例。所有患者均给予吲哚布芬和硫酸氢氯吡格雷抗血小板，阿托伐他汀稳定斑块治疗。对照组给予曲克芦丁治疗，观察组给予纤溶酶注射液联合曲克芦丁治疗。比较两组临床疗效、神经功能、炎症因子指标及不良反应发生情况。结果：观察组总有效率显著高于对照组，差异有统计学意义(P0.05)。结论：采用纤溶酶注射液联合注射用曲克芦丁治疗ACI效果显著，对患者神经功能、炎症反应均有改善作用，同时不良反应发生较少。

    【关键词】 急性脑梗死 纤溶酶 曲克芦丁 神经功能 炎症因子 不良反应

    Effect of Fibrinogenase Injection Combined with Troxerutin for Injection in the Treatment of Acute Cerebral Infarction/CAO Juan， LI Ping. //Medical Innovation of China， 2024， 21(13)： 0-028

    [Abstract] Objective： To investigate the effect of Fibrinogenase Injection combined with Troxerutin for Injection in the treatment of acute cerebral infarction (ACI). Method： A total of 70 patients with ACI who were admitted to Yichun Second People's Hospital from January 2022 to August 2023 were selected as the study subjects， were divided into control group and observation group by random number table method ......